(Q36017621)
Statements
Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders (English)
Stuart A Lipton
1 December 2004